Laura Heller supports clients in navigating the regulatory strategy and FDA policy environment.
Trained as a biochemist, she applies her background in pharmaceutical development to support a broad range of clients by translating technical information and providing in-depth clinical knowledge.
Prior to joining Avalere, Laura held a postdoctoral position researching infectious diseases at Georgetown University Medical Center where she gained significant experience in drug development. She also served as a part-time consultant for a start-up company, VitamInfuse, where she offered scientific guidance for the creation of new IV therapy products. Laura's interests include projects related to gene therapy, oncology, rare disease, and drug and device regulatory policy.
Laura has a PhD in chemistry from Georgetown University and a BA in chemistry and art history from Franklin & Marshall College.